Association between Beverage Consumption and Environmental Sustainability in an Adult Population with Metabolic Syndrome.
Silvia GarciaMargalida Monserrat-MesquidaEmma ArgelichLucía UgarrizaJordi Salas SalvadóInmaculada BautistaJesús VioqueMaría Dolores ZomeñoDolores CorellaXavier PintoBueno-Cavanillas ALidia Daimiel RuizJ Alfredo MartínezStephanie K NishiEstefanía Herrera-RamosSandra González-PalaciosMontserrat FitóEva María Asensio-MárquezMarta Fanlo-MaresmaNaomi Cano-IbánezEsther Cuadrado-SotoJosé Alfredo MartínezJosep Antonio TurCristina BouzasPublished in: Nutrients (2024)
Beverages are an important part of the diet, but their environmental impact has been scarcely assessed. The aim of this study was to assess how changes in beverage consumption over a one-year period can impact the environmental sustainability of the diet. This is a one-year longitudinal study of 55-75-year-old participants with metabolic syndrome (n = 1122) within the frame of the PREDIMED-Plus study. Food and beverage intake were assessed using a validated food frequency questionnaire and a validated beverage-specific questionnaire. The Agribalyse ® 3.0.1 database was used to calculate environmental impact parameters such as greenhouse gas emission, energy, water, and land use. A sustainability beverage score was created by considering the evaluated environmental markers. A higher beverage sustainability score was obtained when decreasing the consumption of bottled water, natural and packed fruit juice, milk, and drinkable dairy, soups and broths, sorbets and jellies, soft drinks, tea without sugar, beer (with and without alcohol), and wine, as well as when increasing the consumption of tap water and coffee with milk and without sugar. Beverage consumption should be considered when assessing the environmental impact of a diet. Trial registration: ISRCTN, ISRCTN89898870. Registered 5 September 2013.
Keyphrases
- life cycle
- human health
- metabolic syndrome
- physical activity
- risk assessment
- weight loss
- clinical trial
- type diabetes
- insulin resistance
- randomized controlled trial
- cardiovascular disease
- uric acid
- cross sectional
- adverse drug
- patient reported
- psychometric properties
- weight gain
- cardiovascular risk factors
- electronic health record